Research & Development



  蘭喬問道。色天使   只要狗子這家伙活著回來了,雲瑯懸著的心也就放下來了,雲氏小門小戶的就那麼幾個心腹家人,哪個都損失不起。七七色   張安世有些羞愧的低下了頭。   “家主為了把你這只土狗從匈奴弄回來,開出來了五百金的賞格。昨晚你安穩的在家睡大覺的時候,劉二已經帶著五百金去給人家送錢去了。家里的帳必須要弄平,這麼大的一筆支出,我做主從你的例份里扣除了。你听著,你這幾年的例份已經被扣光了,不但這幾年的例份沒有了,接下來的十年中,你如果沒有做出特殊的貢獻,休想從我這里拿走一個錢!”超碰   不是你有多麼的喜歡她們,而是那兩個女人代表著你好的一面,你舍不得放棄。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo